Skip to content

Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

The RAISE Study: Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07139769
Acronym
RAISE
Enrollment
48
Registered
2025-08-24
Start date
2026-09-01
Completion date
2027-01-01
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiving for Cancer

Keywords

adolescents and young adults with cancer, cancer caregivers

Brief summary

The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP (E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYAs with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.

Interventions

BEHAVIORALPsychosocial Intervention for Parental Caregivers of AYA with Cancer

A new adaptation of an evidence-supported intervention, the SMART-3RP program, to address psychological symptoms and promote well-being among parental caregivers of AYA with cancer.

Sponsors

Zeba Ahmad, Ph.D.
Lead SponsorOTHER
American Cancer Society, Inc.
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer * Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer at the Mass General Brigham Cancer * Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer * English-speaking * Aged over 18 years

Exclusion criteria

-Active symptoms of psychosis or suicidal ideation that would preclude safe participation

Design outcomes

Primary

MeasureTime frameDescription
Intervention Feasibility: Percent of Identified Prospective Participants Who EnrollPost-treatment completion (enrollment to treatment completion is approximately 3 months)Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.
Intervention Feasibility: Proportion of Participants Completing the ProgramPost-treatment completion (enrollment to treatment completion is approximately 3 months)Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.
Intervention AcceptabilityPost-treatment completion (enrollment to treatment completion is approximately 3 months)Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).

Countries

United States

Contacts

CONTACTZeba N Ahmad, Ph.D.
zahmad2@mgh.harvard.edu16177241586
CONTACTKatana Corning, B.A.
kcorning@mgh.harvard.edu6177247593

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026